# Gem Aromatics share price today (Gem Aromatics Ltd, NSE: GEMAROMA)

> Gem Aromatics share price today: ₹137.01 at the NSE close on 3 November 2026, down 38.8% in a year. Gem Aromatics (NSE: GEMAROMA) is worth ₹716 crore, trades at a P/E of 29.6 and has closed between ₹134.63 and ₹211.06 over the past 52 weeks. > Gem Aromatics Ltd's share price has risen faster than its earnings: −38.8% in a year, against −97.6% for earnings per share. GEMAROMA · Chemicals - Organic · data as of 3 November 2026. Page: https://www.sectoralpha.in/stocks/gem-aromatics-ltd

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Price: ₹137.01 (−38.8% in a year)
- P/E: 29.6× (higher than 67% of the last 8 months)
- Revenue (Sep 2026): ₹104 Cr (+16.2% on a year ago)
- Profit (Sep 2026): −₹7.0 Cr
- Operating margin: 7.6% (+4.2 points on a year ago)
- ROCE: 3%, FY26
- ROIC: −0.7%, against a 12.0% cost of capital: −12.7 points
- Profit that came in as cash: 43%, last 3 years

The main question: profits are rising, but only 43% of the last 3 years' profit came in as cash from operations. The gap between reported profit and actual cash is the thing to watch. ## What is the Gem Aromatics share price today? Gem Aromatics Ltd's share price was ₹137.01 at the close on 3 November 2026. It has been falling for 62 weeks. That is 22.6% below its average price over the last 200 trading days. In the last 52 weeks it traded between ₹135 and ₹211, and at that close it sat 3% of the way up from that low. Over the past 13 weeks it has done worse than the NIFTY 500, and it has been behind for 13 weeks running. Over the last 1 year the share price moved −50% while the NIFTY 500 moved −4%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 7 August 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What changed at Gem Aromatics this quarter? 2 points on a year earlier. 1. Profit down on a year earlier for 6 quarters in a row (every quarter we can compare) In the September 2026 quarter profit was ₹-7 crore, -172.1% on a year earlier. 2. Operating margin up 4.2 points on a year earlier 7.6% in the September 2026 quarter, from 3.4%. ## What are Gem Aromatics' latest quarterly results? For July to September 2026 (the quarter ended 30 September 2026), Gem Aromatics reported revenue of ₹104 crore, up 16.2% from ₹89.5 crore a year earlier, and a loss of ₹7.02 crore. ### Gem Aromatics results: July to September 2026 against a year earlier

| Measure | July to September 2026 | July to September 2025 | Change |
| --- | --- | --- | --- |
| Revenue | ₹104 crore | ₹89.5 crore | +16.2% |
| Profit | loss of ₹7.02 crore | loss of ₹2.58 crore | n/a |
| Earnings per share | ₹−1.34 | ₹−0.49 | n/a |
| Operating margin | 7.6% | 3.4% | +4.2 points |

The next results, for October to December 2026, are due by 14 February 2027: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter). The newest call in our records is from 14 August 2026, about April to June 2026; a call about these results is not in our records yet. (From the company's reported quarterly results (quarter ended 30 September 2026). Revenue and profit in ₹ crore.)

## What is the Gem Aromatics share price history? Gem Aromatics closed at ₹137.01 on 3 November 2026, down 38.8% from ₹224.02 a year earlier (31 October 2025). Its highest weekly close since August 2025 was ₹290.00 on 12 September 2025. ### Gem Aromatics share price: then and now

| When | Close | Change to 3 Nov 2026 |
| --- | --- | --- |
| 1 week ago · 23 Oct 2026 | ₹135.23 | +1.3% |
| 1 month ago · 1 Oct 2026 | ₹155.28 | −11.8% |
| 6 months ago · 30 Apr 2026 | ₹163.57 | −16.2% |
| 1 year ago · 31 Oct 2025 | ₹224.02 | −38.8% |
| Earliest weekly close in our records · 29 Aug 2025 | ₹276.15 | −50.4% |
| Highest weekly close since August 2025 · 12 Sep 2025 | ₹290.00 | −52.8% |
| Lowest weekly close since August 2025 · 23 Oct 2026 | ₹135.23 | +1.3% |
| 52-week high (weekly close) · 7 Nov 2025 | ₹211.06 | −35.1% |
| 52-week low (weekly close) · 10 Dec 2025 | ₹134.63 | +1.8% |

Weekly closing prices. Each change is the move from that price to the 3 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes. (66 weekly closes from 29 August 2025 to 3 November 2026.)

## What is the latest news on Gem Aromatics? 3 Nov 2026: Gem Aromatics closed at ₹137.01, up 1.3% on the week and down 11.8% on the month. Results for July to September 2026: Revenue up 16.2% on a year earlier. ### Earlier

- 14 Aug 2026: Gem Aromatics held its results call for April to June 2026. Management guided: Safranal revenue contribution towards the end of July to September 2026, with a more meaningful contribution from October to December 2026 as supplies scale. ## What dividend does Gem Aromatics pay? Gem Aromatics has paid no dividend on the NSE since its first NSE close in our records (29 August 2025), the start of the period we checked. No. Gem Aromatics Ltd paid out 0% of its profit as dividends in each of its last 6 reported years, so there is no payout history to show. That comes from the filed annual statements, not an estimate. (From the NSE corporate-actions record, read 4 November 2026.)

## What did Gem Aromatics management say on the latest results call? On the call for April to June 2026, held on 14 August 2026, Gem Aromatics' management guided: Safranal revenue contribution towards the end of July to September 2026, with a more meaningful contribution from October to December 2026 as supplies scale. > “For FY27, we do not want to provide guidance on that. However, through FY28, Crystal products will account for more than 50% of overall revenue.”
> Advik, on the call for April to June 2026

### What management guided

- Cooling agents: meaningful revenue contribution from October to December 2026, with revenues building through Q3-Q4 as qualifications and recurring supplies scale. - Phenol derivatives: trial production towards the end of July to September 2026, commercial production planned in Q3, meaningful revenue contribution in Q4. - New specialty verticals: FY27 is a ramp-up year, with a large portion of volumes expected through FY28. - Krystal products to account for more than 50% of overall revenue through FY28. Management’s own plans and goals, from our notes of the call. A plan is not a result. Source: [the call transcript](https://files.tijorifinance.com/insight/india/58681/Conference Call/CC-Aug26.pdf). (From the call for April to June 2026, 14 August 2026. The July to September 2026 results are out since, so this part may be out of date until we update it.)

## What to watch in Gem Aromatics' next results? When Gem Aromatics reports October to December 2026, these are the 4 checks that show whether the story is still on course. First: Consolidated profitability improving as Dahej utilization rises and higher-value product revenue reaches the P&L. - What to check (from the call)
- Consolidated profitability improving as Dahej utilization rises and higher-value product revenue reaches the P&L. - Cooling-agent orders and Safranal approvals converting into recurring commercial supplies. - Phenol trials and quality approvals advancing toward commercial production. - Clove and eugenol export flow normalising after Madagascar supply and Western Hemisphere shipping disruptions. ## Which stock lists is Gem Aromatics on? Gem Aromatics is on one of our India lists: 52 week high & low. [52 week high & low 52-week position: Near 52-week low](https://www.sectoralpha.in/52-week-high-stocks-india)

## Is Gem Aromatics profitable? Gem Aromatics Ltd posted a net loss of ₹7.0 Cr in the Sep 2026 quarter. Full-year FY26 profit was ₹1.0 Cr. Over 5 years profit has grown −46.6% a year on average. That loss is 6.7% of the quarter's revenue. The same quarter a year earlier lost ₹2.6 Cr. 4 of the last 10 reported quarters were loss-making. For the full year, FY26 profit was ₹1.0 Cr (−98.1% on the year before). On average over the last four quarters, profit changed −153.9% and revenue −8.7%. Profit is growing slower than sales: rising costs are taking part of the growth. ## How much revenue does Gem Aromatics make, and is it growing? Gem Aromatics Ltd reported ₹104 Cr of revenue in the Sep 2026 quarter, +16.2% on the same quarter a year earlier. That is the 2nd quarter in a row with growth on the year before. Over 5 years it has grown 3.6% a year on average. The last full year, FY26, came in at ₹366 Cr. The last four reported quarters add to ₹392 Cr. FY26 revenue was ₹366 Cr, −27.4% on the year before. Recent pace: the last four quarters grew −8.7% on average, against 3.6% a year over the longer run, so this year is growing slower than its own long-run rate. ## How much of every ₹100 of sales does Gem Aromatics keep? Gem Aromatics Ltd's operating margin was 7.6% in the Sep 2026 quarter, 4.2 percentage points higher than the same quarter a year ago. Across 6 years it has been between 10.0% and 18.0%. The latest quarter is below every full year in that period. Why the margin moved: operating margin changed +4.2 percentage points on the year while gross margin changed +11.4 points. So the gain came mostly from the gross margin, which means input costs and prices charged. ## Is Gem Aromatics' profit turning into cash? Over the last 3 years, 43% of Gem Aromatics Ltd's reported profit came in as cash from its operations, a gap worth watching. In FY26 it brought in ₹30.0 Cr of operating cash against ₹1.0 Cr of profit. After ₹102 Cr of spending on assets, free cash was −₹72.0 Cr: it spent more than its operations brought in. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why 43% of profit came in as cash: the cash cycle got 200 days longer between FY21 and FY26, so more of each rupee of profit waits in the business before it arrives. When less than 70% of profit comes in as cash, it is the thing to watch on this page. What to look at next: less of the profit turns into cash than it should, and the cash cycle is 200 days longer. The next section looks at where the cash is stuck. ## Where does Gem Aromatics' cash go? Gem Aromatics Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 360 days in FY26, up from 160 days in FY21. It spent ₹248 Cr on assets over the last 3 years. Customers take 76 days to pay, and stock sits for 309 days on average. At FY26 sales of ₹366 Cr, each day of that cycle ties up about ₹1.0 Cr, so roughly ₹361 Cr is tied up in the business at any time. FY26: customers took 76 days to pay and stock sat for 309 days, about 10.2 months of sales sitting as stock, for a full cycle of 360 days, longer than FY21's 160. The full loop: cash goes out to suppliers and production on day 0. Stock sits for 309 days. Customers pay about 76 days after that. Suppliers are paid at 25 days. Together that makes the 360-day cycle. Spending on assets: ₹248 Cr over the last 3 years, against ₹36.0 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹6.0 Cr (FY26): assets paid for that are not earning yet. In short: cash is getting stuck in the daily cycle, so watch the cycle more than the profit. ## What is Gem Aromatics' P/E ratio, and how does it compare with its own history? Gem Aromatics Ltd's P/E is 29.6×, in the middle of its own history: higher than 67% of past readings. Its usual P/E (the middle reading) is 26.8×, over 8 months of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year earnings per share moved −97.6% while the price moved −38.8%. The price did better than earnings, which pushed the multiple up within its own range. In short: the multiple is high against its own past, so the earnings trend underneath matters more than the multiple. ## Is the Gem Aromatics business getting better or worse? Gem Aromatics Ltd's business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. This is based on 6 quarters of 1 measure, with some gaps. Why it matters: with too little history, we say so rather than guess a direction. One or more growth lines have an extreme jump caused by comparing with a near-zero or loss-making quarter. Those jumps are capped before reading and drawn at the edge of the chart, so one odd quarter does not decide the result. There are fewer than eight usable quarters, so this page does not guess a direction from so little history. ## How much does Gem Aromatics earn on its capital? Gem Aromatics Ltd earned a ROCE of 3% in FY26. Its return on capital used (ROIC) is 12.7 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a 0.3% net margin and 0.57× asset turnover (sales divided by assets). Why the return is what it is (FY26): a 0.3% net margin × 0.57× asset turnover × 1.43× leverage (assets divided by equity) ≈ 0.2% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed. The key test, return on capital used minus the cost of capital: −0.7% − 12.0% = −12.7 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve. The −0.7% ROIC above is the latest reading, as reported. The yearly chart below shows FY26 at 0.7%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method. ## Does Gem Aromatics have too much debt? Gem Aromatics Ltd has total debt of ₹152 Cr against shareholder equity of ₹450 Cr as of Jun 2026, so its debt is 0.34× its equity. Year by year, that ratio went from 0.80 in FY25 to 0.34 in FY26. Keep that borrowing in mind when reading the returns on this page. ## What is the Gem Aromatics shareholding pattern? Promoters raised their stake in Gem Aromatics Ltd by 2.4 percentage points over 4 quarters, the biggest change among its owners. Promoters now own 57.4% of the company. Foreign institutions moved −1.6 points over the same period, to 0.4%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings. Over the last two years: Promoters: +2.4 points over 4 quarters, to 57.4%; Foreign institutions: −1.6 points over 4 quarters, to 0.4%; Domestic institutions: −1.6 points over 4 quarters, to 5.0%. Why the owners changed: promoters drove it (+2.4 points), with the other side taken by foreign institutions (−1.6 points). They raised their stake step by step. ## How far is Gem Aromatics from balance-sheet trouble? For Gem Aromatics Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date. ## How does Gem Aromatics rank in its industry? 32.2 out of 100, rank 17 of 20 in Chemicals - Organic, with 51% of the evidence available. Gem Aromatics Ltd scores 32.2 out of 100 against the 20 companies it is compared with in Chemicals - Organic, ranking 17. Some evidence is missing, so the score is pulled toward the middle on purpose. The four parts add up to the total exactly: 10.2 + 4.5 + 10 + 7.5 = 32.2. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Gem Aromatics compared with? Gem Aromatics ranks 17 of 20 Chemicals - Organic companies on the 4-Factor Sector Score, with 32.2 out of 100. 1. [Nitta Gelatin India Ltd](https://www.sectoralpha.in/stocks/nitta-gelatin-india-ltd) NITTAGELA · quiet · Most evidence points up · 85% evidence 76.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 30.4/35 · Revenue 15% · Profit 49.4% · Operating margin change 9 points · 100% evidence Capital efficiency 21.3/25 · ROCE 27.7% · Operating margin 28% · 100% evidence Valuation 13.2/20 · P/E 12.1× · PEG 0.95 · 100% evidence Relative strength 12.0/20 · Lead over its industry n/a · Lead over NIFTY 500 35.5% · 1 year n/a · 25% evidence · 5 of 12 weeks ahead Exact sum: 30.4 + 21.3 + 13.2 + 12 = 76.9 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 2. [Indo Amines Ltd](https://www.sectoralpha.in/stocks/indo-amines-ltd) INDOAMIN · losing its lead · Most evidence points up · 81% evidence 66.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.8/35 · Revenue 13.3% · Profit 24.2% · Operating margin change 3 points · 88% evidence Capital efficiency 16.8/25 · ROCE 18.9% · Operating margin 14% · 100% evidence Valuation 19.0/20 · P/E 10.6× · PEG 0.32 · 100% evidence Relative strength 9.5/20 · Lead over its industry n/a · Lead over NIFTY 500 2.3% · 1 year -10.4% · 25% evidence · 4 of 12 weeks ahead Exact sum: 20.8 + 16.8 + 19 + 9.5 = 66.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [Valiant Organics Ltd](https://www.sectoralpha.in/stocks/valiant-organics-ltd) VALIANTORG · breaking out · Evidence leans up · 78% evidence 61.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.4/35 · Revenue 1.5% · Profit 100% · Operating margin change 6 points · 83% evidence Capital efficiency 9.0/25 · ROCE 5.5% · Operating margin 18% · 76% evidence Valuation 10.9/20 · P/E 23.2× · PEG n/a · 50% evidence Relative strength 19.8/20 · Lead over its industry 24.1% · Lead over NIFTY 500 48.6% · 1 year 39.6% · 100% evidence · 10 of 12 weeks ahead Exact sum: 21.4 + 9 + 10.9 + 19.8 = 61.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. [OCCL Ltd](https://www.sectoralpha.in/stocks/occl-ltd) OCCLLTD · breaking out · Too little evidence to rank firmly · 56% evidence 59.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.6/35 · Revenue 40.6% · Profit 100% · Operating margin change 7 points · 83% evidence Capital efficiency 12.3/25 · ROCE 13% · Operating margin 28% · 76% evidence Valuation 11.1/20 · P/E 11× · PEG n/a · 15% evidence Relative strength 12.1/20 · Lead over its industry n/a · Lead over NIFTY 500 45.3% · 1 year n/a · 25% evidence · 12 of 12 weeks ahead Exact sum: 23.6 + 12.3 + 11.1 + 12.1 = 59.1 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. 5. [BASF India Ltd](https://www.sectoralpha.in/stocks/basf-india-ltd) BASF · quiet · Evidence leans up · 71% evidence 57.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.8/35 · Revenue 6.5% · Profit 62.4% · Operating margin change 4 points · 88% evidence Capital efficiency 11.7/25 · ROCE 14.5% · Operating margin 10% · 100% evidence Valuation 14.1/20 · P/E 21.4× · PEG n/a · 50% evidence Relative strength 7.7/20 · Lead over its industry n/a · Lead over NIFTY 500 -13% · 1 year -30.9% · 25% evidence · 5 of 12 weeks ahead Exact sum: 23.8 + 11.7 + 14.1 + 7.7 = 57.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. [Elantas Beck India Ltd](https://www.sectoralpha.in/stocks/elantas-beck-india-ltd) ELANTAS · leader · Evidence leans up · 67% evidence 57.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.7/35 · Revenue 18.7% · Profit 35.5% · Operating margin change 1 points · 95% evidence Capital efficiency 18.1/25 · ROCE 21.2% · Operating margin 23% · 76% evidence Valuation 6.5/20 · P/E 54.1× · PEG n/a · 50% evidence Relative strength 11.8/20 · Lead over its industry n/a · Lead over NIFTY 500 31.9% · 1 year 33.1% · 25% evidence · 12 of 12 weeks ahead Exact sum: 20.7 + 18.1 + 6.5 + 11.8 = 57.1 · What this means: A strong business with a high valuation: it would need rising earnings, or a lower multiple, to score better on value. 7. [Fine Organic Industries Ltd](https://www.sectoralpha.in/stocks/fine-organic-industries-ltd) FINEORG · leader · Evidence leans up · 96% evidence 56.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 13.9/35 · Revenue 7.1% · Profit 5.8% · Operating margin change 4 points · 88% evidence Capital efficiency 17.8/25 · ROCE 21.5% · Operating margin 25% · 100% evidence Valuation 15.0/20 · P/E 35.3× · PEG 0.58 · 100% evidence Relative strength 9.9/20 · Lead over its industry -7.6% · Lead over NIFTY 500 12.4% · 1 year 13.8% · 100% evidence · 9 of 12 weeks ahead Exact sum: 13.9 + 17.8 + 15 + 9.9 = 56.6 · What this means: The valuation scores well, but earnings are not improving yet, so the business does not back up the low multiple so far. 8. [Laxmi Organic Industries Ltd](https://www.sectoralpha.in/stocks/laxmi-organic-industries-ltd) LXCHEM · quiet · Evidence leans up · 81% evidence 54.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.1/35 · Revenue 5.5% · Profit 26% · Operating margin change 7.6 points · 88% evidence Capital efficiency 10.8/25 · ROCE 4.7% · Operating margin 12% · 100% evidence Valuation 13.1/20 · P/E 33.8× · PEG 1.14 · 100% evidence Relative strength 9.2/20 · Lead over its industry n/a · Lead over NIFTY 500 1.8% · 1 year -22% · 25% evidence · 10 of 12 weeks ahead Exact sum: 21.1 + 10.8 + 13.1 + 9.2 = 54.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. [Balaji Amines Ltd](https://www.sectoralpha.in/stocks/balaji-amines-ltd) BALAMINES · quiet · Evidence leans up · 78% evidence 53.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.2/35 · Revenue 11.1% · Profit 41.6% · Operating margin change 10 points · 83% evidence Capital efficiency 13.1/25 · ROCE 11% · Operating margin 25% · 76% evidence Valuation 9.1/20 · P/E 28× · PEG n/a · 50% evidence Relative strength 8.2/20 · Lead over its industry -2.5% · Lead over NIFTY 500 15.2% · 1 year 25.3% · 100% evidence · 6 of 12 weeks ahead Exact sum: 23.2 + 13.1 + 9.1 + 8.2 = 53.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. [Fairchem Organics Ltd](https://www.sectoralpha.in/stocks/fairchem-organics-ltd) FAIRCHEMOR · quiet · Evidence leans up · 100% evidence 53.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 30.3/35 · Revenue 17.1% · Profit 100% · Operating margin change 6.2 points · 100% evidence Capital efficiency 7.0/25 · ROCE 3.3% · Operating margin 10% · 100% evidence Valuation 13.0/20 · P/E 32.7× · PEG 0.84 · 100% evidence Relative strength 3.0/20 · Lead over its industry -15.4% · Lead over NIFTY 500 3.2% · 1 year -15.9% · 100% evidence · 9 of 12 weeks ahead Exact sum: 30.3 + 7 + 13 + 3 = 53.3 · What this means: Earnings are strong; relative strength in its sector is -15.4% and the one-year return is -15.9%. 11. [Sigachi Industries Ltd](https://www.sectoralpha.in/stocks/sigachi-industries-ltd) SIGACHI · breaking out · Evidence leans down · 100% evidence 49.4 out of 100 Growth Capital Valuation Relative
12. [GFL Ltd](https://www.sectoralpha.in/stocks/gfl-ltd) GFLLIMITED · breaking out · Evidence leans down · 71% evidence 48.6 out of 100 Growth Capital Valuation Relative
13. [Jyoti Resins and Adhesives Ltd](https://www.sectoralpha.in/stocks/jyoti-resins-and-adhesives-ltd) JYOTIRES · basing · Evidence leans down · 74% evidence 43.7 out of 100 Growth Capital Valuation Relative
14. [Foseco India Ltd](https://www.sectoralpha.in/stocks/foseco-india-ltd) FOSECOIND · leader · Evidence leans down · 81% evidence 41.1 out of 100 Growth Capital Valuation Relative
15. [Shree Ganesh Remedies Ltd](https://www.sectoralpha.in/stocks/shree-ganesh-remedies-ltd) SGRL · breaking out · Evidence leans down · 85% evidence 40.3 out of 100 Growth Capital Valuation Relative
16. [Oriental Aromatics Ltd](https://www.sectoralpha.in/stocks/oriental-aromatics-ltd) OAL · leader · Evidence leans down · 74% evidence 36.5 out of 100 Growth Capital Valuation Relative
17. Gem Aromatics Ltd this page GEMAROMA · quiet · Too little evidence to rank firmly · 51% evidence 32.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 10.2/35 · Revenue -17.6% · Profit -80% · Operating margin change 4.2 points · 74% evidence Capital efficiency 4.5/25 · ROCE 3.4% · Operating margin 7.6% · 80% evidence Valuation 10.0/20 · P/E n/a · PEG n/a · 0% evidence Relative strength 7.5/20 · Lead over its industry n/a · Lead over NIFTY 500 -14.8% · 1 year -38.8% · 25% evidence · 2 of 12 weeks ahead Exact sum: 10.2 + 4.5 + 10 + 7.5 = 32.2 · What this means: Some evidence is missing, so the score is pulled toward the middle on purpose. 18. [Sacheerome Ltd](https://www.sectoralpha.in/stocks/sacheerome-ltd) SACHEEROME · losing its lead · Too little evidence to rank firmly · 36% evidence 58.1 out of 100 Growth Capital Valuation Relative
19. [Shri Ahimsa Naturals Ltd](https://www.sectoralpha.in/stocks/shri-ahimsa-naturals-ltd) SHRIAHIMSA · leader · Too little evidence to rank firmly · 47% evidence 56.8 out of 100 Growth Capital Valuation Relative
20. [Citurgia Biochemicals Ltd](https://www.sectoralpha.in/stocks/citurgia-biochemicals-ltd) CITURGIA · Too little evidence to rank firmly · 25% evidence 34.3 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Chemicals - Organic](https://www.sectoralpha.in/sectors/chemicals-organic), all 20 compared on one page. ## Which companies are close to Gem Aromatics in size? Gem Aromatics is the 19th largest of 20 Chemicals - Organic companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: Indo Amines, Valiant Organics, OCCL, Fairchem Organics and Shree Ganesh Remedies. Just below it: GFL. ### Chemicals - Organic companies close in size

1. [Indo Amines Ltd](https://www.sectoralpha.in/stocks/indo-amines-ltd) ₹865 crore
2. [Valiant Organics Ltd](https://www.sectoralpha.in/stocks/valiant-organics-ltd) ₹864 crore
3. [OCCL Ltd](https://www.sectoralpha.in/stocks/occl-ltd) ₹841 crore
4. [Fairchem Organics Ltd](https://www.sectoralpha.in/stocks/fairchem-organics-ltd) ₹801 crore
5. [Shree Ganesh Remedies Ltd](https://www.sectoralpha.in/stocks/shree-ganesh-remedies-ltd) ₹792 crore
6. Gem Aromatics Ltd ₹716 crore
7. [GFL Ltd](https://www.sectoralpha.in/stocks/gfl-ltd) ₹568 crore

[All 20 Chemicals - Organic companies, largest first](https://www.sectoralpha.in/sectors/chemicals-organic#all-companies)

### Companies close in size in other industries

1. [Sterling Tools Ltd](https://www.sectoralpha.in/stocks/sterling-tools-ltd) ₹719 crore · Castings, Forgings & Fastners
2. [Welspun Investments & Commercials Ltd](https://www.sectoralpha.in/stocks/welspun-investments-commercials-ltd) ₹718 crore · Finance - Investment/Others
3. Gem Aromatics Ltd ₹716 crore
4. [NCL Industries Ltd](https://www.sectoralpha.in/stocks/ncl-industries-ltd) ₹715 crore · Cement
5. [Everest Industries Ltd](https://www.sectoralpha.in/stocks/everest-industries-ltd) ₹714 crore · Pre-Engineering Buildings

## What else do people ask about Gem Aromatics? ### What were Gem Aromatics's latest quarterly results? Gem Aromatics Ltd reported revenue of ₹104 Cr and a net loss of ₹7.0 Cr for the Sep 2026 quarter. Earnings per share were −₹1.34. The operating margin was 7.6%, 4.2 percentage points higher than a year earlier (as of 3 November 2026). ### What is Gem Aromatics's market cap? Gem Aromatics Ltd's market capitalisation is ₹716 Cr at a share price of ₹137.01. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Gem Aromatics performing? Gem Aromatics Ltd's share price has been falling for 62 weeks. Over the past 13 weeks it has done worse than the NIFTY 500, for 13 weeks running. This describes what the data did, not a rating (as of 3 November 2026). ### Will Gem Aromatics's share price go up? This page does not forecast Gem Aromatics Ltd's share price. What it shows instead: the share price is ₹137.01, and it has been falling for 62 weeks. Its P/E of 29.6× is higher than 67% of its own last 1 years (as of 3 November 2026). ### Who owns Gem Aromatics? Promoters own 57.4% of Gem Aromatics Ltd, foreign institutions 0.4%, domestic institutions 5.0% and the public 37.2% (latest quarter). The biggest change over the last two years: Promoters raised their stake by 2.4 percentage points over 4 quarters (as of 3 November 2026). ### Does Gem Aromatics have too much debt? Gem Aromatics Ltd has a moderate amount of debt: its debt is 0.34× its equity, and its operating profit is 3 times its interest bill. FY26 borrowings were ₹152 Cr against equity of ₹449 Cr. Keep that borrowing in mind when reading the returns on this page (as of 3 November 2026). ### Where is Gem Aromatics in its business cycle? Gem Aromatics Ltd's FY26 operating margin was 11.0%, against a 6-year range of 10.0% to 18.0%: the low end of its own range, which is often where recoveries start. The latest quarter was 7.6%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Gem Aromatics story? The main question: profits are rising, but only 43% of the last 3 years' profit came in as cash from operations. The gap between reported profit and actual cash is the thing to watch. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Gem Aromatics a stock worth studying right now? What the numbers show: Gem Aromatics Ltd's share price has risen faster than its earnings: −38.8% in a year, against −97.6% for earnings per share. The main open question: whether the cash starts to follow the profit. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). ### Is there a Gem Aromatics share price forecast for 2026? What management itself guided: Safranal revenue contribution towards the end of July to September 2026, with a more meaningful contribution from October to December 2026 as supplies scale. ## Lists

- 52 week high & low: https://www.sectoralpha.in/52-week-high-stocks-india

This is research, not advice. We’re not SEBI-registered.